You Are Here: Home > Get Involved > Participate > Events > Biologics, Biosimilars and JAK Inhibitors
Go Back to Events

Biologics, Biosimilars and JAK Inhibitors

Host: Dr. Alan Low


1 hrs

Presentation slides (PDF, 2 MB)

Medications provide an important option to help you treat your arthritis – yet understanding the options available and determining the right one for you can be overwhelming. The good news is that medications on the market today are safer and more effective than ever before, and for those living with inflammatory arthritis, they can slow down the progression of the disease. In this Arthritis Talks, Clinical Pharmacist Dr. Alan Low, will provide you with important information about three cutting-edge types of medications – biologics, biosimilars and Janus kinase (JAK) inhibitors. This webinar discusses:

  • Similarities and differences between biologics and biosimilars
  • When and where JAK inhibitors may be a suitable treatment option
  • Current research related to inflammatory arthritis medications
  • How to work with your healthcare provider to make informed decisions about your medications